ARCA Hero Image
Investor Relations

Press Releases

[+view all]
06.20.2017
ARCA BIOPHARMA ANNOUNCES DATABASE LOCK FOR GENETIC-AF PHASE 2B INTERIM EFFICACY ANALYSIS – DSMB RECOMMENDATION ANTICIPATED IN AUGUST 2017
05.15.2017
ARCA biopharma Announces First Quarter 2017 Financial Results and Provides Business Update
04.26.2017
ARCA biopharma Announces 200th Patient Randomized into the GENETIC-AF Seamless Design Phase 2B/3 Clinical Trial
Investor Relations

Press Releases

[+view all]
06.20.2017
ARCA BIOPHARMA ANNOUNCES DATABASE LOCK FOR GENETIC-AF PHASE 2B INTERIM EFFICACY ANALYSIS – DSMB RECOMMENDATION ANTICIPATED IN AUGUST 2017
05.15.2017
ARCA biopharma Announces First Quarter 2017 Financial Results and Provides Business Update
04.26.2017
ARCA biopharma Announces 200th Patient Randomized into the GENETIC-AF Seamless Design Phase 2B/3 Clinical Trial
ir-presentations
Presentations
[GO]
ir-reports
Annual Financial Reports
[GO]
ir-filings
SEC Filings
[GO]
ir-faq
Frequently Asked Questions
[GO]

Stock Information | ABIO

$2.4

Arca Biopharma Inc | NASDAQ: ABIO

Data as of 07/25/2017
00:00:00 ET
Minimum 15 minute delay
ir-corp-gov

Corporate Governance

Committee Charters

PDF Icon
Audit Committee
PDF Icon
Compensation Committee
PDF Icon
Nominating & Governance Committee

Governance Documents

PDF Icon
Board of Directors Corporate Governance Principles
PDF Icon
ARCA biopharma, Inc. Code of Business Conduct and Ethics
PDF Icon
ARCA biopharma, Inc. Complaint and Investigation Policy and Procedure
PDF Icon
Contact the Board
Chairperson
Member
Chairperson
Member
Audit Committee
Compensation Committee
Nominating & Governance Committee
Raymond L. Woosley, M.D., Ph.D.
Member
Chairperson
Linda Grais, M.D.
Member
Chairperson
Robert E. Conway
Chairperson
Member
Dan Mitchell
Member
Member
Anders Hove, M.D.
Member